Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ten Most Popular Healthcare Stocks Among Hedge Funds

By compiling 13F filings from hedge funds and other major investors in our database, we are able to analyze which stocks are in the highest favor with these class of market participants. By adding more information we are not only able to produce a list of the most popular stocks among hedge funds but also to rank stocks in different categories, such as by sector. We have gone through our data and have prepared a list of the most popular healthcare-sector stocks among hedge funds, ranked by the number of funds in our database reporting a position on their 13F. Read on for the full list or see the top ten healthcare stocks from the first quarter.

Pfizer Inc. (NYSE:PFE). Pfizer topped our list last quarter and while a couple of hedge funds left the stock- with 75 reporting positions, down from 77 in the first quarter- it remained at the top of the list as well as being the only healthcare stock to make the overall top ten. Tiger Cub Rob Citrone’s Discovery Capital Management increased its stake in Pfizer by 48% during the quarter and according to the 13F it is now one of the fund’s top five holdings (see more of Discovery’s favorite stocks).

Warren Buffett portrait

Johnson & Johnson (NYSE:JNJ). Several hedge funds initiated positions in Johnson & Johnson during the second quarter, bringing it from 61 owners to 72. Warren Buffett’s Berkshire Hathaway sold about two-thirds of its shares but still finished June with over 10 million shares of the company. Johnson & Johnson trades at 21 times trailing earnings and pays a dividend yield of 3.6%.

Express Scripts Holding Company (NASDAQ:ESRX). The pharmacy benefit management company had a bit of a spat this year with Walgreens, and has meanwhile been integrating Medco Health Solutions’ operations. 62 hedge funds owned the stock at the end of June, unchanged from the previous quarter. Billionaire Stephen Mandel’s Lone Pine Capital was the largest hedge fund holder in our database, with 7.2 million shares. Find more stock picks from Stephen Mandel.

UnitedHealth Group Inc. (NYSE:UNH). We covered UnitedHealth Group last month, before 13F filings were released. Now we can see that 55 funds had a position in the stock at the end of the second quarter, up from 47 at the end of March. UnitedHealth and other insurers are trading at low multiples as investors worry about federal interference with health insurance markets; UnitedHealth’s trailing P/E is 11 and its forward P/E is 10.

Sanofi SA (ADR) (NYSE:SNY). Sanofi claimed the #2 spot on this list a quarter ago, but the number of hedge funds reporting positions fell from 62 to 55. Billionaire Ken Fisher’s Fisher Asset Management owned over 14 million shares at the end of June. Sanofi, a $108 billion market cap drug manufacturer, trades at a trailing P/E of 13 and pays a 4.1% dividend yield. The stock is up about 18% over the last year, roughly even with the market.

WellPoint, Inc. (NYSE:WLP). 53 hedge funds reported positions in WellPoint, up from 52. First Eagle Investment Management increased its stake in the health insurer to 6.8 million shares. Like UnitedHealth, WellPoint trades at value levels: a trailing P/E of 8. Year to date the stock is down 13% as the company missed earnings last quarter and the fourth quarter of last year.

Merck & Co., Inc. (NYSE:MRK). A few hedge funds initiated positions in Merck during the quarter, and the drug manufacturer climbed from 45 hedge fund holders to 49. Merck trades at 20 times trailing earnings and pays a high dividend yield of nearly 4%. Point State Capital, run by several former portfolio managers at Duquesne Capital, was one owner of the stock.

Abbott Laboratories (NYSE:ABT). 45 hedge funds owned Abbott Laboratories at the end of June, down from 48 three months earlier. Diamond Hill Capital owned 3.7 million shares of the stock, making it one of the fund’s top positions.

Aetna Inc. (NYSE:AET). 34 hedge funds reported positions of Aetna at the end of the first quarter, and over the second quarter that number grew to 44, vaulting the insurer onto the top ten list. Billionaire David Einhorn’s Greenlight Capital initiated a position in the stock.

HCA Holdings Inc. (NYSE:HCA). About a month ago, we looked at HCA Holdings. The number of hedge funds owning the stock stayed constant between the beginning and the end of the second quarter, at 43. The hospital owner and operator trades at 5 times trailing earnings.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!